Literature DB >> 34341

Impaired renal tubular potassium secretion in sickle cell disease.

R A DeFronzo, P A Taufield, H Black, P McPhedran, C R Cooke.   

Abstract

We examined renal tubular function in six patients with sickle cell hemoglobin. All had normal inulin and para-aminohippurate clearances and impaired urinary concentrating and acidifying abilities. After intravenous potassium chloride administration, maximum excretion of potassium (U,V) was significantly lower in sickle cell patients than in control subjects, and the percentage of potassium load excreted in 5 h was markedly reduced. Urinary potassium excretion after sodium sulfate infusion was also markedly reduced in sickle cell patients compared to control subjects. After 40 mg of oral furosemide, U,V was also diminished in sickle cell patients. Plasma aldosterone response to ACTH and intravenous potassium was similar to that of control subjects. Plasma renin activity increased normally after volume contraction. We conclude that sickle cell patients have a defect in their ability to excrete an acute potassium load that cannot be attributed to abnormal renin or aldosterone secretion. Overall potassium homeostasis is maintained by extrarenal mechanisms during acute potassium loading.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34341     DOI: 10.7326/0003-4819-90-3-310

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.

Authors:  Lauren J Becton; Ram V Kalpatthi; Elizabeth Rackoff; Deborah Disco; John K Orak; Sherron M Jackson; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2010-05-27       Impact factor: 3.714

Review 2.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

3.  Hyperkalaemia during massive blood transfusion in paediatric craniofacial surgery.

Authors:  K A Brown; B Bissonnette; M MacDonald; A O Poon
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

4.  Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Authors:  Stéphane Maurel; Katia Stankovic Stojanovic; Virginie Avellino; Alexey Girshovich; Emmanuel Letavernier; Gilles Grateau; Laurent Baud; Robert Girot; Francois Lionnet; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

5.  Anaesthesia for renal transplantation in sickle cell disease.

Authors:  H K Gyasi; A W Zarroug; M Matthew; R Joshi; A Daar
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

6.  Serum urate concentrations in homozygous sickle cell disease.

Authors:  K De Ceulaer; A G Morgan; E Choo-Kang; W A Wilson; G R Serjeant
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

7.  Medical Staff Conference. Tubulo-interstitial nephropathies--a pathophysiologic approach.

Authors:  M G Cogan
Journal:  West J Med       Date:  1980-02

8.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

Review 9.  Sickle cell disease and the kidney.

Authors:  Jon I Scheinman
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-02

10.  Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.

Authors:  A K Gupta; K A Kirchner; R Nicholson; J G Adams; A N Schechter; C T Noguchi; M H Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.